Mark A. Kay

Mark A. Kay

Directeur/Bestuurslid bij
Genevant Sciences Corp.
68 jaar
Consumer Services
Health Technology
Commercial Services

Profiel

Mark A. Kay is the founder of Voyager Therapeutics, Inc. (2013), American Society of Gene & Cell Therapy (2005), and LogicBio Therapeutics, Inc. (2014).
He held the title of President at American Society of Gene & Cell Therapy from 2005 to 2006 and the title of Independent Director at LogicBio Therapeutics, Inc. from 2016 to 2022.
Currently, he is an Independent Director at Genevant Sciences Corp.
since 2018 and a Professor & Head-Human Gene Therapy Division at Stanford University School of Medicine since 1998.
Dr. Kay received his undergraduate degree from Michigan State University and his doctorate from Case Western Reserve University.

Actieve functies van Mark A. Kay

BedrijvenFunctieBegin
Corporate Officer/Principal 01-01-1998
Directeur/Bestuurslid 19-11-2018

Eerdere bekende functies van Mark A. Kay

BedrijvenFunctieEinde
LOGICBIO THERAPEUTICS, INC. Oprichter 16-11-2022
Oprichter 01-01-2006
VOYAGER THERAPEUTICS, INC. Oprichter -
Ervaring van Mark A. Kay in detail bekijken

Opleiding van Mark A. Kay

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

72

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Mark A. Kay